Jun 4 |
Eli Lilly and Company (LLY) Lilly Oncology ASCO Investor Event (Transcript)
|
Jun 4 |
William Blair Commentary: Waistlines and GLP1-s--Expanding in Unison
|
Jun 4 |
ETFs to Profit from the Weight Loss Drug Boom
|
Jun 4 |
Eli Lilly sees improving availability of GLP-1 drugs Mounjaro and Zepbound
|
Jun 4 |
Melissa Seymour to join Lilly as executive vice president of Global Quality
|
Jun 3 |
Eli Lilly Beefs Up Neuro Pipeline With Addition Of Preclinical ALS, Dementia Prospect
|
Jun 3 |
Structure Therapeutics' Obesity Candidate Is ' Very Competitive' To Eli Lilly's Orforglipron, Analyst Says
|
Jun 3 |
LLY Stock Today: How To Trade An Unbalanced Iron Condor That May Put $285 In Your Pocket
|
Jun 3 |
Beyond The Nvidia Juggernaut: 2 Chip Giants, 2 Drugmakers In Spotlight
|
Jun 3 |
Structure Therapeutics Stock Skyrockets To Six-Month High On Compelling Weight-Loss Drug Results
|